PT-141 - Generic Peptides

Buy PT-141 10 mg by Generic Peptides at XSteroids. PT-141 is bremelanotide, a melanocortin receptor agonist peptide that works through the central nervous system rather than through blood flow. The Generic Peptides listing is one lyophilized vial of 10 mg. This page covers what the molecule is, why it is described as a libido peptide, the licensed product it shares a molecule with, and the side effects that matter most.

Bremelanotide exists as a prescription medicine under the name Vyleesi. The lyophilized vial on this page is a research format and is not that licensed product, so it has no approved label and no approved dose. The notes below are educational.

What PT-141 by Generic Peptides Is and What You Are Buying

One glass vial arrives, holding 10 mg of white lyophilized powder. Water for mixing is not part of the order and must be bought separately, and the contents have to be dissolved before any bench work. The label carries the substance and the milligram amount, and nothing further: no filler breakdown and no third party potency report are published for the lot.

Bremelanotide is what melanotan II becomes in the body; the active metabolite is missing the C-terminal amide group. In the brain the peptide acts on melanocortin receptors, MC4 above all. That is a different route from the familiar erectile drugs: instead of widening blood vessels, it influences the desire and arousal side of the sexual response, which is why it is grouped with the sexual health peptides rather than the performance pills.

The purchase is the active substance in a research format. Vyleesi is the approved injectable with its own label, safety data and dose; the vial here is a different article, sold without an approved indication or patient leaflet.

How PT-141 Works in the Brain

Central action, not blood flow

Melanocortin receptors in the brain are part of the circuitry that governs sexual motivation. By acting on MC4, bremelanotide affects desire rather than circulation, and the two pathways are separate enough that a PDE5 inhibitor and this peptide are often described as solving different halves of the same problem. That central mechanism is the genuine difference between this peptide and a blood-flow drug.

Duration after a dose

The half-life is about 2.7 hours, with a reported range of 1.9 to 4.0 hours, and the peptide is cleared mainly through the urine, with the rest in the faeces. The effect is therefore relatively short lived compared with a daily blood-flow drug, and that short window shapes how the licensed product is used on an as-needed basis.

What to Expect from PT-141 Research

The controlled human data comes from studies in premenopausal women with hypoactive sexual desire disorder, the population the licensed product was approved for. In those trials the measured endpoint was an increase in satisfying sexual events and in desire scores, with an effect that separated from placebo but was modest at the individual level. The injection is used on demand rather than daily.

For men, and for recreational use, the published evidence is much thinner; the compound is widely discussed as a libido peptide, but that reputation rests largely on user reports rather than on controlled trials. Around 40 percent of treated people in the trials reported nausea, a reminder that the effect and the side effect come from the same central mechanism. Anyone expecting the predictable reliability of a blood-flow pill is likely to be disappointed, because the peptide acts on desire signalling, not on mechanics.

PT-141 Dosing and Reconstitution

What the approved label uses

The licensed product is given as a 1.75 mg subcutaneous injection on demand. That figure belongs to the approved medicine with its own label and safety data, not to a research vial. There is no approved dose for a lyophilized research product, so any number here is background rather than instruction.

Mixing a PT-141 vial

Mixing 2 ml of bacteriostatic water into the 10 mg vial yields 5 mg per ml, which puts 1.75 mg at 0.35 ml, or 35 units on a U-100 insulin syringe, with 1 mg at 20 units. Using 1 ml instead doubles the concentration to 10 mg per ml, so 1.75 mg becomes 17.5 units. Let the water run down the inside wall and rotate the vial rather than shaking it.

Storage of the mixed solution

Storage for the licensed medicine is set out in its own paperwork. Nothing has been validated for a research vial, so the practical limit is 2 to 8 C in a refrigerator with the mixed solution used inside roughly four weeks. Freezing the solution is not advisable.

Stacking PT-141 in Research Practice

PT-141 is a peptide with a specific job, and it is not stacked in any established protocol. It comes up alongside the other sexual health chemicals in the catalog: Melanotan II 5 mg, which is the parent compound and acts on the same receptor family, and Kisspeptin-10, which is studied on the hormonal side of libido rather than the central melanocortin side. Hormonal context sometimes includes HCG 5000 IU and Somatropin 100 IU, while Ipamorelin 5 mg, Sermorelin 5 mg and BPC-157 5 mg appear in general recovery research. None of these combinations has been formally studied with PT-141.

Recovery and Research Context for PT-141

There is no cycle and no recovery protocol for PT-141, because it is not a muscle or hormone compound. It is used on an as-needed basis in the licensed setting and researched as a single agent. The honest framing is that it addresses desire signalling, not performance physiology, and anyone reading about it in a bodybuilding context is reading user experience rather than trial data. Published controlled evidence comes from studies in women with a diagnosed desire disorder, which is a different population from the gym.

PT-141 Side Effects and Safety Notes

Reported effects

Nausea is by far the most common reaction, reported by roughly 40 percent of people in trials against about 8 percent on placebo. Flushing, headache and injection site reactions also appear. Most are transient and described as mild to moderate, and they tend to ease with repeated use.

Hyperpigmentation

A separate and well documented effect is darkening of the skin, including on the face and gums, which is linked to repeated use over time. It can be slow to fade. Anyone who has noticed this with melanotan II should treat the same possibility as real with bremelanotide.

General precautions

The licensed product carries warnings about blood pressure changes, so it should not be combined with blood pressure medicines without medical advice, and it is not intended for people with uncontrolled hypertension. No significant interaction with alcohol has been shown. This page is research context and not medical advice.

Anti-doping note

No published WADA rule names bremelanotide specifically, and there is no separate anti-doping decision to cite. Related melanocortin compounds such as melanotan II are controlled in various countries for non-medical supply. The accurate statement is that no specific sport prohibition is published, not that the peptide is cleared.

Storage of the PT-141 Vial

Unopened powder belongs at 2 to 8 C away from light, and it can go into a freezer when the wait is longer. After mixing, hold the solution at 2 to 8 C and finish it inside about four weeks; freezing it is not recommended. These are the usual laboratory habits for peptides rather than directions from a label, since no label exists for this vial.

Why Buy PT-141 10 mg from XSteroids?

Ordering PT-141 from Generic Peptides at XSteroids delivers one labelled 10 mg research vial that matches the pack details on this page. Payment runs through a secure checkout, domestic US parcels land in 3 to 6 days and international ones in 12 to 26 days. Since the same molecule is sold as a licensed medicine, this page states plainly that the vial is a research format and not the approved drug.